Ownership history in STRS OHIO · 14 quarters on record
This page tracks every 13F SEC filing in which STRS OHIO reported a position in D BIOCRYST PHARMACEUTICALS INC COM (BCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 40,700 | — | 0% | 0.00% | $309K | $7.59 |
| 2025 Q2 | ADDED | 40,700 | +2,900 | +7.7% | 0.00% | $365K | $8.96 |
| 2025 Q1 | ADDED | 37,800 | +36,300 | +2420.0% | 0.00% | $284K | $7.50 |
| 2022 Q3 | REDUCED | 1,500 | -500 | -25.0% | 0.00% | $18K | $12.60 |
| 2022 Q1 | REDUCED | 2,000 | -1,400 | -41.2% | 0.00% | $32K | $16.26 |
| 2021 Q3 | REDUCED | 3,400 | -13,000 | -79.3% | 0.00% | $48K | $14.37 |
| 2020 Q2 | REDUCED | 16,400 | -2,500 | -13.2% | 0.00% | $78K | $4.76 |
| 2010 Q1 | ADDED | 18,900 | +4,400 | +30.3% | 0.00% | $124K | $6.57 |
| 2009 Q4 | REDUCED | 14,500 | -18,800 | -56.5% | 0.00% | $94K | $6.46 |
| 2009 Q3 | REDUCED | 33,300 | -19,171 | -36.5% | 0.00% | $274K | $8.24 |
As of 2025 Q4 — sorted by position size